Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes is a paper indexed in PICO Portal from OpenAlex.
How many citations does Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes have?
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes has 67 citations in the OpenAlex counts PICO Portal stores.
When was Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes published?
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes has 2019 year in the PICO Portal index.
What is the open-access status of Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes?
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes has closed oa status in the PICO Portal index.
What is the DOI of Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes?
The DOI for Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes is on the source record.
What is the PMID of Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes?
The PMID for Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes is on the source record.
What is the OpenAlex record for Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes?
The OpenAlex for Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes is on the source record.